November 16, 2023
- November 01, 2023 - Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed). See NOFO PAR-24-039.
National Cancer Institute (NCI)
The purpose of this Notice is to clarify the eligibility of Program Directors/Principal Investigators (PDs/PIs) in PAR-24-039 "Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)"
The following section of the NOFO is revised accordingly:
Part 2. Section III. Eligibility Information
Eligible Individuals (Program Director/Principal Investigator)
Currently, reads:
Eligible Individuals (Program Director/Principal Investigator)
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
Revised to read (in bold italics):
Eligible Individuals (Program Director/Principal Investigator)
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
Current or former PDs/PIs on an NIH research project grant (such as an R01), or any peer-reviewed non-NIH research grant over $175,000 direct costs per year are not eligible. Current or former PD(s)/PI(s) of an NIH R03 or R21 grant, or a non-federal equivalent to an R03 or R21 grant remain eligible.
An individual may receive no more than 2 awards from the Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research program, including past and future iterations of this NOFO.
By the time of award, the individual must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possesses a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status.
All other aspects of this NOFO remain unchanged,
Scientific/Research Contact(s)
Laritza Rodriguez MD, PhD
National Cancer Institute (NCI)
Telephone: 240-477-9376
Email: laritza.rodriguez@nih.gov
Sangeeta Ghosh, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-742-5707
Email: sangeeta.ghosh@nih.gov
Financial/Grants Management Contact(s)
Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 202-276-5699
Email: Dawn.Mitchum@nih.gov
and Human Services (HHS)
